grim grimmer grimmestSo:
Assuming we sell AH @ ~$60M, we'll be able to (sort of) pay off our debts. (I'm guessing there'll be little left of that money once all the advisors, consultants and lawyers are paid off.)
The VMC is being mothballed and awaiting sale, assuming there's anyone out there interested in it. I've lost track of the certification process and am no longer sure it's approved to produce anything at this time.
The recent meeting with the U.S. FDA did not result in a shorter pathway to commercialization - and we don't have the money for any further trials on our own.
Our only path forward is to hope that commercialization will result from Cdn gov't approval sometime in 2015, assuming they don't ask for more info in the meantime.
What have I left out - oh yeah, we've hired a new COO to help manage - what exactly?
Anyone bothering to go to T.O. in April and witness this sad debacle?
QA